HIV Services

Services Include:

  • Medical Care
  • Mental Health Services
  • Dental Care
  • Confidential HIV Antibody Testing
  • Medical HIV Case Management

More about ourHIV Services

Available Programs for People Living with HIV/AIDS:

  • AIDS Drug Assistance Program, ADAP, Recertification.
  • Insurance plan through Covered CA, if you are over income for Medi-Cal.
  • COBRA monthly premium payments.
  • Medicare Part D monthly premiums.
  • Medi-Gap monthly premiums.

Additional Programs for HIV Prevention:

  • HIV Pre-Exposure Prophylaxis: PrEP AP

Contact Chris Hightower 707-823-3204 for enrollment in any of these programs.


WCHC offers a full range of consultation, diagnostic and treatment services for all stages of HIV disease. Individuals may enter our primary care practice at any point in the disease process and know that WCHC providers will maintain responsibility for their lifelong clinical care. All services are offered by highly qualified, licensed professionals with extensive HIV training and experience.

WCHC offers individual short-term and long-term counseling to people infected with or affected by HIV. Individual counseling involves ongoing, biweekly sessions to explore personal issues and provide one-on-one support. Group counseling is available for gay men with HIV/AIDS. The group experience is designed to help offset the isolation that many living in the epidemic feel, as well as providing a “safe place” to express some of the feelings being withheld in other relationships.

WCHC is committed to quality, specialized oral health care for persons who are immunocompromised. Our staff is trained and experienced in providing HIV dental care. Services offered include preventative care, general dentistry, single crowns, root canals and dentures.

For information on the latest research, including information on clinical trials, medication studies, and other types of HIV-related medical investigations, please visit


COVID Related Information

NEW UPDATE HIV and COVID-19 booster vaccination:

The Centers for Disease Control (CDC) has recently revised their SARS-COV-2 vaccination guidance to recommend a third “booster” vaccine for those who have “moderate to severe immune compromise” and who have previously received either of the mRNA vaccines (either the Moderna or the Pfizer vaccines). 

The recommendation for a booster vaccine does not apply to those who received the Janssen (“J&J”) vaccine.

Relevant questions in response to the CDC guidance are: what is the evidence that guides that decision, and what constitutes “moderate to severe immune compromise?”

According to diverse sets of data presented at a meeting of the Advisory Committee on Immunization Practices (ACIP) in July, 2021, certain immunocompromised populations were studied to measure vaccine effectiveness after one, two, and three doses of an mRNA vaccine dose.  It was clear that antibody response improved in most cases after a third dose of vaccine.

None of the studies included people living with HIV infection as a primary diagnosis; the immunocompromising conditions of the people studied included: a history of a solid organ transplant, hemodialysis, current cancer treatment, and current immunosuppressive therapy.  Most of the studies from which those data were collected were quite small, most under 100 people, which does tend to impair generalization of the findings, however, it was those and similar data that led to the “booster” vaccine recommendation.

A few countries have instituted a “booster dose” policy; these policies are similar to the CDC’s recommendation in that they suggest the booster for certain immunocompromising conditions but do not explicitly list HIV infection as one of those conditions. 

The conditions and treatments associated with moderate to severe immune compromise include:

  • Active or recent treatment for solid tumor and hematologic malignancies
  • Receipt of solid-organ or recent hematopoietic stem cell transplant
  • Severe primary immunodeficiency
  • Advanced or untreated HIV infection
  • Treatment with immunosuppressive medications such as cancer chemotherapeutic agents, TNF blockers, certain biologic agents (e.g., rituximab), and high-dose corticosteroids

The ACIP also suggested that some chronic conditions are associated with varying degrees of immune deficit, such as asplenia (absence of a spleen) and chronic renal disease, and that people with those conditions could also be considered for a booster vaccine dose.

Based on the available data and recommendations, WCHC is encouraging a booster vaccine dose for patients living with HIV infection who also have any of the conditions or are undergoing treatments listed above.   For the most part, people living with HIV who are on antiretroviral treatment and have a suppressed or undetectable viral load for greater than 12 months would not fall into the “moderately to severely immunocompromised” category.  However, if you are unsure, please speak with your provider and/or your Care Team RN.

If you do have one of the listed conditions, or are receiving treatment for cancer, or are receiving immunosuppressive treatments for other conditions, you can go to to search for a vaccination site and to schedule an appointment.  You will need to attest that you have one of the above immune deficiency conditions or circumstances.

Please reach out to your Care Team members for questions or clarification.  You can reach Amy Puckett, Care Management Assistant for both Russian River Health Center and Gravenstein Community Health Center on her direct line at (707) 328-7390.



HIV and COVID-19 booster vaccination – August 2021

COVID-19 FAQ July 2020 – WCHC HIV Services

Healthcare Team Letter – COVID-19

CDC COVID-19: What people with HIV should know

Information on COVID-19 for People Living with HIV

Updates on HIV Resources during COVID-19

Sex and Coronavirus Disease 2019: NYC Health- Tips on How to Enjoy Sex and Avoid Spreading COVID-19 



Translate This Page: